245.97
West Pharmaceutical Services Inc (WST) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
9.81%
766.50
|
698.00 | 748.80 | 746.90 | 702.10 |
Cost Of Revenue |
5.69%
492.60
|
466.10 | 475.20 | 482.20 | 472.10 |
Gross Profit |
18.11%
273.90
|
231.90 | 273.60 | 264.70 | 230.00 |
|
3.76%
120.20
|
124.90 | 114.00 | 103.40 | 103.80 |
Benefits Costs and Expenses |
3.74%
609.50
|
587.50 | 583.90 | 582.40 | 573.40 |
Costs And Expenses |
3.74%
609.50
|
587.50 | 583.90 | 582.40 | 573.40 |
Operating Income/Loss |
43.64%
153.70
|
107.00 | 159.60 | 161.30 | 126.20 |
Income/Loss Before Equity Method Investments |
42.08%
157.00
|
110.50 | 164.90 | 164.50 | 128.70 |
Income/Loss From Equity Method Investments |
47.06%
5.00
|
3.40 | 2.00 | 3.90 | 4.50 |
Income/Loss From Continuing Operations Before Tax |
42.08%
157.00
|
110.50 | 164.90 | 164.50 | 128.70 |
Income Tax Expense/Benefit |
25.31%
30.20
|
24.10 | 36.80 | 32.40 | 21.90 |
Income/Loss From Continuing Operations After Tax |
41.20%
126.80
|
89.80 | 128.10 | 132.10 | 111.30 |
|
46.77%
131.80
|
89.80 | 130.10 | 136.00 | 111.30 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
0.41%
72.20
|
72.50 | -0.10 | 72.80 | 73.00 |
Diluted Average Shares |
0.68%
72.50
|
73.00 | -0.10 | 73.40 | 73.70 |
Basic Earnings Per Share |
46.77%
1.82
|
1.24 | 1.79 | 1.87 | 1.52 |
Diluted Earnings Per Share |
47.97%
1.82
|
1.23 | 1.78 | 1.85 | 1.51 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):